Louvain la Neuve, Belgium, 1st October 2019 / Sciad Newswire / N-SIDE, provider of innovative software and strategic consulting services, announced that AstraZeneca has signed an agreement to implement the N-SIDE Suite for Clinical Trials. Within the scope of this agreement, AstraZeneca will use specifically the N-SIDE Supply and Dashboard Apps in order to design, plan and monitor their clinical trial supply chain.
John Murray, Supply Chain Transformation Lead at AstraZeneca, commented: “N-SIDE’s Suite provides a tremendous opportunity for AstraZeneca to collaborate across key areas of clinical development and deliver the best studies for our patients."
Thanks to the N-SIDE Suite for Clinical Trials, AstraZeneca will achieve a centralization of their clinical supply chain management. The N-SIDE solution will support both strategic decision-making during protocol design as well as operational planning and change management of on-going trials. The business intelligence dashboards will be used for real-time trial monitoring, results visualization and supporting cross-department communication.
"We are proud to further our collaboration with AstraZeneca as they implement the N-SIDE Suite for Clinical Trials to manage their clinical supply chain” stated Jacques Parlongue, N-SIDE CEO. N-SIDE has provided consulting services for AstraZeneca clinical trial supply optimization since 2017.
The N-SIDE Suite for Clinical Trials is a cutting edge, cloud-based software that enables clinical trial managers to future-proof their clinical trial supply chain management while minimizing costs, drug waste and risk. With interconnected applications, the N-SIDE Suite for Clinical Trials uses advanced analytics, including optimization and machine learning, to support strategic and operational decision-making as well as facilitate trial monitoring with real-time data and knowledge sharing.
Notes to Editors
N-SIDE is an innovative software consulting company in advanced analytics designing optimization solutions for supply chain, operation and energy management. N-SIDE optimizes decisions of some of the largest companies around the world, across a vast range of industries including pharmaceuticals, chemicals, steel, pulp & paper and energy. N-SIDE uses cloud-based cutting-edge technologies and powerful algorithms, such as artificial intelligence and machine learning to solve the most complex industry challenges and turn them into opportunities. N-SIDE’s solutions empower organizations to make agile data-driven decisions to optimize processes and use resources wisely while efficiently managing risk and maximising profits. N-SIDE has been an active player in clinical trial supply forecasting and simulation for more than 15 years. To learn more, visit www.n-side.com.
For further information, please contact:
Sylvia Haller, Life Sciences Marketing Manager
Deborah Cockerill / Juliette Craggs
T: +44 (0)20 3755 0571